Qisheng Feng
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Enhanced rhLCV production in lymphoblastoid cell lines derived from rhLCV-infected cynomolgus macaque PBMCs.
Journal: Journal of virology
Published: January 27, 2026
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk.
Journal: Nature
Published: July 14, 2025
A Comparative Study of Epstein-Barr Virus Genomes Detected in Tumor, Nasopharyngeal Swab, and Saliva Samples From Patients With Nasopharyngeal Carcinoma.
Journal: The Journal of infectious diseases
Published: December 05, 2024
TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice.
Journal: Emerging microbes & infections
Published: October 10, 2024
Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics.
Journal: Viruses
Published: March 24, 2024
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection.
Journal: Nature communications
Published: September 20, 2023
Expression of cytoskeleton-associated protein 4 is associated with poor prognosis and metastasis in nasopharyngeal carcinoma.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: May 20, 2023
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 02, 2022
Urgency and necessity of Epstein-Barr virus prophylactic vaccines.
Journal: NPJ vaccines
Published: July 26, 2022
Last Updated: 09/26/2026